Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary
hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Pulmonary hypertension (PH) because of chronic lung disease is categorized as Group 3
PH in the most recent classification system. Prevalence of these diseases is increasing over …

Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …

Pulmonary arterial hypertension (PAH) is a rare disease that can be caused by (likely)
pathogenic germline genomic variants. In addition to the most prevalent disease gene …

Idiopathic pulmonary arterial hypertension (IPAH) is a rare but fatal disease diagnosed by
right heart catheterisation and the exclusion of other forms of pulmonary arterial …

Pulmonary arterial hypertension (PAH) is a complex multifactorial disease with poor
prognosis characterized by functional and structural alterations of the pulmonary circulation …

Purpose Pulmonary arterial hypertension (PAH) is a rare, progressive vasculopathy with
significant cardiopulmonary morbidity and mortality. Genetic testing is currently …

Pulmonary hypertension (PH), increased blood pressure in the pulmonary arteries, is a
morbid and lethal disease. PH is classified into several groups based on etiology, but …